Stocks · News reference
GE HealthCare has entered into an agreement to provide high-tech medical equipment to regional cardiology and neurology centers in Uzbekistan as part of a broader healthcare infrastructure initiative.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Following recent quarterly results, several financial institutions, including RBC, Rothschild & Co Redburn, and BNP Paribas, have updated their price targets for GE HealthCare Technologies.
Barclays analyst Christopher Pasquale maintained a "Buy" rating on GE HealthCare Technologies and increased the price target from $85 to $95.